This study proves my point! (edit)
this poor two-year-old girl was suffering extreme symptoms of mercury poisoning. After one month of DMSA treatment all of her systems resolved
There is no mention of an every three hour dosing protocol. And I sincerely doubt her parents were getting up in the middle of the night and giving her DMSA every three hours.
According to Andy, she should've got "permanently worse". But of course she didn't. in fact, she got permanently better.
Again, if you want to tell me that dosing every three hours is the most efficient method of chelating, then I just might agree with you
But if you want to tell me that if you don't follow the every three hours schedule you will get "permanently worse", I just don't see any evidence for that
please somebody show me one single study where humans, rats, or mice, got permanently worse because they didn't stick to a three hour dosing schedule of DMSA and/or DMPS and/or ALA
EDIT- I found the complete study. The child was injected every six hours with DMSA. According to Andy that should have resulted in redistribution and worsening of symptoms. But it didn't
http://medind.nic.in/icb/t10/i10/icbt10i10p1153.pdf
--------------
Abstract
A 2-year-old girl presented with hypertension, anorexia and vomiting, restlessness, insomnia and acrodynia. Her blood pressure upon arrival was 145/98 mmHg. Ultrasound of the abdomen, CT scan of chest, abdomen and pelvis, and echocardiogram, were normal. Urinary levels of catecholamines were elevated, urine level of mercury was found to be high (33.2 μg/g creatinine), although blood level was normal (>0.5 μg/dl, reference value 0–4 μg/dl). Following a 1-month course of oral treatment with dimercaptosuccinic acid (DMSA) the child’s symptoms and signs resolved, and urinary mercury and catecholamines levels normalized. Mercury intoxication should be suspected in a patient with severe hypertension, personality changes and acrodynia. Normal blood levels of mercury do not exclude this diagnosis, and catecholamine levels may serve as a surrogate marker for confirmation of the diagnosis and to evaluate response to treatment.